XENE — Xenon Pharmaceuticals Inc. stock price, charts and financials

QT56Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
64.01
+1.75+2.81%
OverviewShort InterestFilings
XENEQT56Xenon Pharmaceuticals Inc.·NASDAQ
64.01+2.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 22, 2026DEF 14ADefinitive proxy statement
Apr 22, 2026ARSAnnual report to shareholders
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
Apr 13, 2026S-8Registration of employee benefit securities
Apr 13, 20268-KCurrent report
Mar 13, 20264Statement of changes in beneficial ownership
Mar 13, 20264Statement of changes in beneficial ownership
Mar 13, 20268-KCurrent report
#1 / 25 of 255
Page
▼
/ 11